Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene expression biomarkers of response to citalopram treatment in major depressive disorder.

Translational psychiatry - 21 Jun 2011

Mamdani F, Berlim M T, Beaulieu M-M, Labbe A, Merette C, Turecki G

Abstract excerpt

There is significant variability in antidepressant treatment outcome, with ∼30-40% of patients with major depressive disorder (MDD) not presenting with adequate response even following several trials. To identify potential biomarkers of response, we investigated peripheral gene expression patterns of response to antidepressant treatment in MDD. We did this using Affymetrix HG-U133 Plus2 microarrays in blood...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Expression
Share to Antidepressive Agents
Share to Citalopram

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Pharmacogenetics

Share to Prefrontal Cortex

Share to Psychiatric Status Rating Scales

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 22832429
DOI: 10.1038/tp.2011.12
PMCID: PMC3309465

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene expression biomarkers of response to citalopram treatment in major depressive disorder.PMID 22832429Read ↗

Epigenome-Wide DNA Methylation in Unipolar Depression: Predictive Biomarker of Antidepressant Treatment Response?Semantic proximity Read ↗

Gene expression signatures of response to fluoxetine treatment: systematic review and meta-analysesSemantic proximity Read ↗

A genomewide association study of citalopram response in major depressive disorder.Semantic proximity Read ↗

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant responseSemantic proximity Read ↗

Leveraging DNA Methylation to Predict Treatment Response in Major Depressive Disorder: A Critical ReviewSemantic proximity Read ↗

Novel candidate genes for ECT response prediction—a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapySemantic proximity Read ↗

Gene expression: Biomarker of antidepressant therapy?Semantic proximity Read ↗

Dynamic Epigenetic Changes During Antidepressant Pharmacotherapy in Major Depressive DisorderSemantic proximity Read ↗

Are there meaningful biomarkers of treatment response for depression?Semantic proximity Read ↗

Epigenetic Signatures in Antidepressant Treatment Response: a Methylome-wide Association Study in the EMC TrialSemantic proximity Read ↗

Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatmentSemantic proximity Read ↗

Predisposition to treatment response in major depressive episode: A peripheral blood gene coexpression network analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.